Spatiotemporal Omics: Advances to Integrate Multi-Omics Data
View eBook
You’ve discovered some interesting biology and have a set of required parameters, thousands of data points, a budget and a deadline. How can you harness the power of computational chemistry to reach your...
Imlunestrant offers new hope for ER-positive HER2-negative breast cancer
Imlunestrant, an investigational next-generation selective estrogen receptor degrader (SERD), improved progression-free survival in patients with endocrine therapy-pretreated, ER-positive, HER2-negative advanced breast cancer-;as monotherapy in patients with ESR1 mutations and as combination therapy with abemaciclib...
Gene Therapy Reverses Effects of Heart Failure and Restores Heart Function in Minipigs
Researchers at the Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, and the University of Utah School of Medicine, have demonstrated that a gene therapy can reverse the effects of heart...
Scientists uncover genetic code driving tumor formation and spread
A group of scientists at VCU Massey Comprehensive Cancer Center has revealed a new genetic code that acts like a cancer ringleader, recruiting and deploying a gang of tumor cells to incite a biological...
WHO Seeks Expressions of Interest to Join as Regional Biomanufacturing Training Center
The World Health Organization (WHO) is opening its call for expression of interest (EOI) to join as a Regional Biomanufacturing Training Center under the WHO Biomanufacturing Workforce Training Initiative.
The initiative will be coordinated and managed...
Lymphoma Immunotherapy Enhanced by Enzyme Inhibitor In Preclinical Model, Prompting Pilot Clinical Studies
The results of a preclinical study by lymphoma researchers at Weill Cornell Medicine suggest that an emerging class of anticancer drugs called EZH2 inhibitors may greatly enhance the potency of some cancer immunotherapies.
EZH2 enzyme...
StockWatch: ARK Mostly Bullish on CRISPR Therapeutics
CRISPR Therapeutics (NASDAQ: CRSP) made history a year ago this month when the FDA approved Casgevy® (exagamglogene autotemcel), the CRISPR-edited therapy it co-developed with Vertex Pharmaceuticals (NASDAQ: VRTX), to treat sickle cell disease (SCD)....
SigRM offers breakthrough in single-cell epitranscriptomics analysis
Researchers have developed a new tool that will help scientists study how genes are expressed in our cells. The tool, called SigRM, is used to analyze data from single-cell epitranscriptomics, a method for studying...
Pregnancy and breastfeeding cause major changes in mothers’ intestines
When women are pregnant and nurse their babies, their bodies change and various organs, such as the breasts or the immune system, are adapted to ensure the health of both mother and child. This...
Its Revolutionary Potential as a Liquid Biopsy Sample
View eBook
You’ve discovered some interesting biology and have a set of required parameters, thousands of data points, a budget and a deadline. How can you harness the power of computational chemistry to reach your...
